自愿承诺体现联合创始人及基石投资者对公司长期发展前景、业务基础及战略方向的坚定信心，彰显其 长期持有公司股份的意愿并支持公司实现可持续增长及价值创造。根据自愿承诺，于2026年2月23日起 的12个月期间内：联合创始人各自已承诺不会出售任何相关股份；基石投资者已承诺将持有其不少于 80%的相关股份。 MIRXES-B(02629)高开逾5%，截至发稿，涨5.56%，报25.04港元，成交额464.09万港元。 消息面上，2月11日，MIRXES-B发布公告，涉及联合创始人及基石投资者所持公司相关股份的现有禁 售承诺将于2026年2月23日届满。于现有禁售期届满后，联合创始人，即朱兴奋博士(持有3241.94万股 股份)、周砺寒博士(透过SLW Gene Limited持有控制1866.06万股股份)及邹瑞阳博士(透过Accurate Gene Limited持有控制1786.06万股股份)，以及基石投资者北京浔瑞企业管理合伙企业(有限合伙)(持有1664.92 万股股份)已就上述各自于公司的股权自愿向公司作出承诺。 ...

Core Viewpoint - MIRXES-B (02629) shares opened over 5% higher and are currently up 5.56% at HKD 25.04, with a trading volume of HKD 4.6409 million [1] Group 1: Shareholder Commitments - On February 11, MIRXES-B announced that the existing lock-up commitments of its co-founders and cornerstone investors will expire on February 23, 2026 [1] - After the expiration of the current lock-up period, co-founders Dr. Zhu Xingfen (holding 32.4194 million shares), Dr. Zhou Lihan (controlling 18.6606 million shares through SLW Gene Limited), and Dr. Zou Ruiyang (controlling 17.8606 million shares through Accurate Gene Limited), along with cornerstone investor Beijing Xunrui Enterprise Management Partnership (Limited Partnership) (holding 16.6492 million shares), have voluntarily committed to the company regarding their respective equity [1] - The voluntary commitment reflects the co-founders' and cornerstone investors' strong confidence in the company's long-term development prospects, business fundamentals, and strategic direction, demonstrating their willingness to hold shares for the long term and support sustainable growth and value creation [1] Group 2: Commitment Details - According to the voluntary commitment, during the 12-month period starting from February 23, 2026, the co-founders have committed not to sell any of their relevant shares, while the cornerstone investor has committed to holding at least 80% of their relevant shares [1]

Core Viewpoint - MIRXES-B (stock code: 2629.HK) announced a voluntary 12-month shareholding commitment from its co-founders and cornerstone investors, reflecting their confidence in the company's long-term development and strategic direction [1] Group 1: Shareholding Commitment - The co-founders have committed not to sell any of their shares for 12 months starting from February 23, 2026 [1] - Cornerstone investors have pledged to retain at least 80% of their shares during the same period [1] - This commitment follows a previous extension of the lock-up period from 6 months to 9 months, demonstrating ongoing confidence in the company [1] Group 2: Shareholder Details - The co-founders include Zhu Xingfen (holding approximately 32.42 million shares), Zhou Lihan (controlling approximately 18.66 million shares through SLW Gene Limited), and Zou Ruiyang (controlling approximately 17.86 million shares through Accurate Gene Limited) [1] - The cornerstone investor, Beijing Xunrui Enterprise Management Partnership (Limited Partnership), holds 16.65 million shares [1] Group 3: Implications of the Commitment - The voluntary commitment signifies the shareholders' strong belief in the company's solid business foundation and strategic direction [1] - This commitment is expected to support the company's sustainable growth and value creation [1]